• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immunity . Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets

tetano

Editor, Senior Moderator
Immunity


. 2021 May 6;S1074-7613(21)00198-9.
doi: 10.1016/j.immuni.2021.05.001. Online ahead of print.
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets


Haley L Dugan[SUP] 1 [/SUP], Christopher T Stamper[SUP] 1 [/SUP], Lei Li[SUP] 2 [/SUP], Siriruk Changrob[SUP] 2 [/SUP], Nicholas W Asby[SUP] 3 [/SUP], Peter J Halfmann[SUP] 4 [/SUP], Nai-Ying Zheng[SUP] 2 [/SUP], Min Huang[SUP] 2 [/SUP], Dustin G Shaw[SUP] 1 [/SUP], Mari S Cobb[SUP] 5 [/SUP], Steven A Erickson[SUP] 2 [/SUP], Jenna J Guthmiller[SUP] 2 [/SUP], Olivia Stovicek[SUP] 2 [/SUP], Jiaolong Wang[SUP] 2 [/SUP], Emma S Winkler[SUP] 6 [/SUP], Maria Lucia Madariaga[SUP] 7 [/SUP], Kumaran Shanmugarajah[SUP] 7 [/SUP], Maud O Jansen[SUP] 8 [/SUP], Fatima Amanat[SUP] 9 [/SUP], Isabelle Stewart[SUP] 2 [/SUP], Henry A Utset[SUP] 2 [/SUP], Jun Huang[SUP] 10 [/SUP], Christopher A Nelson[SUP] 11 [/SUP], Ya-Nan Dai[SUP] 11 [/SUP], Paige D Hall[SUP] 11 [/SUP], Robert P Jedrzejczak[SUP] 12 [/SUP], Andrzej Joachimiak[SUP] 13 [/SUP], Florian Krammer[SUP] 9 [/SUP], Michael S Diamond[SUP] 14 [/SUP], Daved H Fremont[SUP] 11 [/SUP], Yoshihiro Kawaoka[SUP] 15 [/SUP], Patrick C Wilson[SUP] 16 [/SUP]



Affiliations

Abstract

Dissecting the evolution of memory B cells (MBCs) against SARS-CoV-2 is critical for understanding antibody recall upon secondary exposure. Here, we used single-cell sequencing to profile SARS-CoV-2-reactive B cells in 38 COVID-19 patients. Using oligo-tagged antigen baits, we isolated B cells specific to the SARS-CoV-2 spike, nucleoprotein (NP), open reading frame 8 (ORF8), and endemic human coronavirus (HCoV) spike proteins. SARS-CoV-2 spike-specific cells were enriched in the memory compartment of acutely infected and convalescent patients several months post symptom onset. With severe acute infection, substantial populations of endemic HCoV-reactive antibody-secreting cells were identified and possessed highly mutated variable genes, signifying preexisting immunity. Finally, MBCs exhibited pronounced maturation to NP and ORF8 over time, especially in older patients. Monoclonal antibodies against these targets were non-neutralizing and non-protective in vivo. These findings reveal antibody adaptation to non-neutralizing intracellular antigens during infection, emphasizing the importance of vaccination for inducing neutralizing spike-specific MBCs.

Keywords: COVID-19; ORF8; RNA sequencing; SARS-CoV-2; antibody; immunodominance; memory B cell; nucleoprotein; preexisting immunity; spike.
 
Back
Top Bottom